What Nanorepro does

NanoRepro AG is a publicly listed German Consumer-Health platform headquartered in Marburg an der Lahn (Basic Board Frankfurt, ticker NN6, ISIN DE0006577109), founded in 2015 and operating an integrated portfolio across four consumer-health segments: (i) the ZuhauseTEST brand offering 25+ CE-certified rapid self-tests for pregnancy, fertility, allergy, vitamin D, celiac disease, COVID-19, and colorectal cancer screening, built on lateral flow immunoassay technology; (ii) a 50.05% majority stake in Paedi Protect AG, a dermatologically tested baby and children's skincare specialist; (iii) approximately 22.69% economic exposure to Deutsche Kosmetikwerke AG which markets the newkee skincare brand co-founded by athletes Manuel Neuer and Angelique Kerber; and (iv) a 33% stake (with purchase option for further 17.001%) in hyped about science GmbH commercializing the PHLAS cold atmospheric plasma skincare device, with the alphabiol nutritional supplements brand being integrated under the PHLAS umbrella from Q2 2026.

The technical platform underlying the business spans three differentiated technology stacks. Diagnostic self-tests rely on CE-certified lateral flow immunoassays. The PHLAS device leverages Surface-Micro-Discharge cold atmospheric plasma technology, exclusively licensed from the Max Planck Society and based on more than 20 years of research including experiments on the International Space Station; the architecture does not conduct electrical current through the skin and includes replaceable plasma application modules as a recurring revenue driver. The June 2026 FiberSense AG equity conversion gives NanoRepro exposure to a continuous glucose monitoring (CGM) product with more than 100 patents and CE certification as a Class IIb non-implantable medical device (highest available), tapping a global CGM market projected to grow at ~15.4% CAGR to USD 31 billion by 2031.

NanoRepro operates a hybrid B2C/B2B distribution model combining five owned e-commerce storefronts (zuhausetest.de, alphabiol.de, newkee.de, phlas.com, paediprotect.de), an OEM/private-label partnership with dm drogeriemarkt — Germany's largest drugstore chain — for ZuhauseTEST products, distribution through Budnikowsky pharmacy-anchored stores, and Amazon marketplace presence, with the geographic footprint focused on the DACH region and selective European expansion. Customer segments span health-conscious individual consumers, parents of infants with sensitive skin, premium skincare consumers seeking cold plasma–based treatment for acne and rosacea, and (prospectively) diabetes patients via FiberSense CGM. Revenue is generated primarily through one-time sales of consumer diagnostic products and skincare, supplemented by device-plus-consumables revenue from PHLAS; FY2025 holding-level revenue was EUR 4.33 million with consolidated Paedi Protect AG contributing EUR 11.7 million, and the group maintained a 98.2% equity ratio with EUR 37.3 million of equity capital as of June 2025.

Name

Nanorepro

Legal name

NanoRepro AG

Website

https://nanorepro.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

NanoRepro AG is a publicly listed German Consumer-Health platform headquartered in Marburg that develops CE-certified self-tests under ZuhauseTEST and holds equity stakes in skincare and cold plasma device businesses including Paedi Protect AG, newkee, and PHLAS.

Ownership category

akta.pro rank

Product category

Consumer Health Self-Diagnostic Tests

NAICS

Health and Personal Care Retailers (456), Pharmaceutical Preparation Manufacturing (325412)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Baby Skincare (Lotions, Creams, Oils) (CRABAJAB), Kids Skincare (Moisturizers, Sensitive Skin) (CRABAJAI), Sensitive Skin & Barrier Repair (CRABAAAG), Natural/Organic & Clean Skincare (CRABAAAH)

Keywords

• Home diagnostic tests
• Medical self-tests
• Consumer health products
• Dermatological skincare
• Cold plasma devices

Headquarters

HQ city

Marburg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Rapid Diagnostic Tests: Sale of CE-certified self-diagnostic rapid tests (over 25 products including COVID-19, pregnancy, allergy, fertility, vitamin D, colorectal cancer screening) through retail and e-commerce channels.
2. Consolidated Subsidiary Revenue - Paedi Protect AG: Full consolidation of majority-owned Paedi Protect AG (50.05% stake). Revenue 2025: EUR 11.7 million. High-quality, dermatologically tested skincare products for babies and children.
3. B2C E-commerce and Retail Sales: Direct consumer sales through own online shops (zuhausetest.de, alphabiol.de, newkee.de, phlas.com, paediprotect.de) and retail partnerships with dm, Budnikowsky.
4. PHLAS Device and Consumables: Premium cold plasma device (PHLAS) sales combined with recurring revenue from replaceable plasma application modules ('attachments') that require regular replacement. Device-consumable model following established business logic.
5. Financial Participations and Licensing: Equity stakes in FiberSense (converted from licensing agreement), Deutsche Kosmetikwerke AG (~22.69%), hyped about science GmbH (33%). Investment returns and potential licensing royalties.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

NanoRepro AG develops, manufactures, and distributes CE-certified medical self-diagnostic rapid tests (25+ products including pregnancy, fertility, allergy, vitamin D, celiac disease, and colorectal cancer screening) under the ZuhauseTEST brand. The company also markets dermatologically tested skincare for babies and children (PAEDIPROTECT), adult skincare (newkee), nutritional supplements (alphabiol), and a cold plasma skin treatment device (PHLAS), sold direct-to-consumer via brand-owned online shops and through German retail chains such as dm drogerie markt and Budnikowsky.

Product overview

NanoRepro AG is a publicly listed Consumer-Health platform based in Marburg, Germany, that has evolved from an innovation leader in medical rapid diagnostics into an integrated enterprise group. The company operates four distinct business segments: (1) CE-certified self-tests for home use under the ZuhauseTEST brand including Corona tests, pregnancy tests, vitamin D tests, allergy tests, and colorectal cancer screening (25+ products); (2) majority stake in Paedi Protect AG offering dermatologically tested skincare for babies and children; (3) equity participation in Deutsche Kosmetikwerke AG with the newkee skin care brand; and (4) 33% stake in hyped about science GmbH through the PHLAS brand, combining cold plasma technology (plasma care) for skin treatment with integrated nutritional supplements. The portfolio spans rapid diagnostics, dermatological skincare, cold plasma aesthetic devices, and nutritional supplements, unified under shared distribution competencies and synergistic structures with a common goal of making health and wellness more accessible, innovative, and effective.

Differentiator

Problem solved

Functional benefit

Brands

• ZuhauseTEST: CE-certified medical self-tests for home use including pregnancy tests, allergy tests, gastrointestinal health tests, fertility tests, colorectal cancer screening, and COVID-19 rapid tests.
• Alphabiol
• newkee
• PHLAS
• PAEDIPROTECT

Products and services

• ZuhauseTEST Self-Tests Medical self-tests for home use providing rapid diagnostic results. Portfolio includes Corona tests, pregnancy tests, Vitamin D tests, stomach health tests, fertility tests, allergy tests, and colorectal cancer screening tests. CE-certified and available through the zuhausetest.de online shop and drugstore chains. Targeted at health-conscious individual consumers seeking convenient, at-home diagnostics.
• ZuhauseTEST Professional Rapid Tests Professional-grade CE-certified rapid tests for medical practitioners, including Corona rapid tests and five additional tests designed for medical professional use in clinical settings.
• ZuhauseTEST Vitamin D Self-Test Vitamin D self-test for home application providing results within 10 minutes from a finger prick blood sample with color card reading; first home Vitamin D test in the German market without lab submission. Targeted at individual consumers monitoring their vitamin D status.
• PHLAS Cold Plasma Skin Treatment Device Premium cold plasma device for skin treatment based on medically certified 'plasma care' technology. Enables effective, side-effect-free treatment of skin impurities including acne, pimples, rosacea, and perioral dermatitis. Includes replaceable plasma application modules (attachments) that generate recurring consumable revenue. Targeted at premium skincare consumers.
• PAEDIPROTECT Skincare for Babies and Children Dermatologically tested skincare and sunscreen products for babies and children with sensitive skin, featuring natural, health-compatible ingredients. Held as a 50.05% majority stake through Paedi Protect AG. Targeted at parents of infants and young children with sensitive skin.
• newkee Skincare Essential body care skincare products developed by Deutsche Kosmetikwerke AG. Innovative products that protect skin naturally; co-founded with professional athletes Manuel Neuer and Angelique Kerber as brand ambassadors. Targeted at adult skincare consumers.
• ALPHABIOL Nutritional Supplements Nutritional supplements combining science, quality, and everyday usability. Products include collagen with Verisol, curcumin with Cavacurmin, iron preparations, and antioxidant products. Being integrated into the PHLAS brand from Q2 2026. Targeted at health-conscious adult consumers.

Quantifiable outcome

• Paedi Protect AG revenue: EUR 11.7 million (2025), slight increase from EUR 11.5 million (2024)
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• FiberSense AGcoreTechnology or Integration · 17 June 2026NanoRepro converted its 2021 CGM distribution license into an equity stake in FiberSense AG, a Basel-based spin-off from Novartis AG/Ciba Vision. FiberSense received CE certification (Class IIb) on June 10, 2026 for its continuous glucose monitoring system. NanoRepro also provides a €1 million convertible bond. The CGM market is projected to reach USD 31 billion by 2031 (CAGR ~15.4%). Implied equity stake value: approximately €6-10 million.
• Paedi Protect AGcoreStrategic or Co-development PartnerNanoRepro acquired majority stake (50.05%) in Paedi Protect AG, a specialist in high-quality dermatologically tested skincare products for babies and children with natural, health-compatible ingredients. Founded 2013, Paedi Protect has 16 employees and achieved revenue in the low double-digit millions with profitable results. Products include skin care and sunscreen for babies and children with sensitive skin.
• Deutsche Kosmetikwerke AG (newkee)coreStrategic or Co-development PartnerNanoRepro holds approximately 22.69% direct stake in Deutsche Kosmetikwerke AG, developer of the newkee skincare brand. Total economic interest ~33.22% (including Paedi Protect's 21.03% stake). Total voting rights ~43.72%. The company achieved strong growth of +36.8% to €2.59 million revenue in 2025. Celebrity co-founders Manuel Neuer and Angelique Kerber serve as brand ambassadors.
• Manuel Neuer and Angelique KerbermajorGTM or Marketing PartnerProfessional athletes Manuel Neuer (football) and Angelique Kerber (tennis) are co-founders and brand ambassadors of Deutsche Kosmetikwerke AG (newkee). Their involvement brings significant marketing value and brand recognition to the skincare products.
• hyped about science GmbH (PHLAS)coreStrategic or Co-development PartnerNanoRepro holds 33% stake in hyped about science GmbH, developer of PHLAS cold plasma device for dermatological applications. NanoRepro also has purchase option for additional 17.001% stake. Co-founded by Dr. Julia Zimmermann (daughter of Prof. Dr. Gregor Morfill, cold plasma research pioneer). PHLAS integrates NanoRepro's alphabiol supplement brand. Market launch February 2026.
• Newsletter2Go GmbHminorOthersTechnical service provider for email newsletter distribution. Newsletter2Go GmbH, Köpenicker Str. 126, 10179 Berlin, handles investor newsletter distribution for NanoRepro AG. Data processing agreement in place.
• dm drogerie marktcoreChannel Partner/ Reseller/ DistributorMajor German drugstore chain (dm) is a key retail partner for NanoRepro. Partnership includes OEM arrangement for self-tests via Mivolis platform and brand listing. Marketing and sales control transferred to dm partner in certain channels.
• BudnikowskyminorChannel Partner/ Reseller/ DistributorGerman retail chain with pharmacy focus (Budnikowsky) distributes NanoRepro rapid test products. Focus on stores with pharmaceutical emphasis.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Galderma: Switzerland-based pure-play dermatology company combining prescription aesthetics (Restylane, Sculptra) with consumer dermo-cosmetics (Cetaphil). Comparable to NanoRepro's dermatology-and-skincare platform thesis including PHLAS and PAEDIPROTECT.
• ACON Laboratories: US-headquartered global manufacturer of lateral-flow rapid diagnostics (Flowflex COVID tests, pregnancy, fertility). Directly comparable technology base, CE-marking, and OTC/drugstore distribution.
• Dermapharm Holding SE: German specialty pharma focused on dermatology, allergology, and OTC consumer health. Public mid-cap with parallel M&A strategy of buying dermatology brands, the closest like-for-like German listed peer to NanoRepro.
• nal von minden GmbH: German manufacturer of rapid diagnostic tests (drug-of-abuse, infectious disease, fertility, pregnancy). Most direct competitor in ZuhauseTEST's home self-diagnostic category, sharing both DACH distribution and lateral-flow technology.
• Pierre Fabre Group: French dermo-cosmetics and oncology pharma group (A-Derma, Avène, Ducray). Operates a consumer dermatology + medical dermatology hybrid similar to NanoRepro's PHLAS device plus PAEDIPROTECT positioning.

Broad incumbents

• STADA Arzneimittel AG: European OTC consumer health and generics platform headquartered in Germany (Bad Vilbel). Comparable regional scale, OTC retail distribution, and active M&A-driven portfolio expansion across dermatology and consumer health categories.
• Church & Dwight Co., Inc. US consumer-health platform (First Response, Trojan, Batiste) operating branded OTC health and personal care products in retail. Comparable brand-portfolio-and-distribution playbook to NanoRepro's multi-brand consumer health strategy.
• Beiersdorf AG: German personal-care multinational (Eucerin, La Prairie, NIVEA) and the closest large incumbent to NanoRepro's German dermatology/skin-health platform. Both anchor consumer health narratives through dermatologically validated skincare.
• QuidelOrtho Corporation: US diagnostics company with Triage rapid-test platform, QuickVue at-home diagnostics, and Sofia lateral-flow products. Established peer in professional and at-home rapid diagnostics across infectious disease, fertility, and women's health.
• Abbott (Diagnostics): Global diagnostics incumbent with FreeStyle Libre continuous glucose monitoring franchise — the principal addressable competitor for FiberSense AG's CGM ambitions and adjacent to NanoRepro's diagnostic test portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanorepro